{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:05:19Z","timestamp":1768320319316,"version":"3.49.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274457"],"award-info":[{"award-number":["82274457"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The relationship between hemorrhagic transformation (HT) and uric acid (UA) remains controversial. This study aimed to investigate the relationship between UA concentrations and the risk of HT following acute ischemic stroke (AIS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Electronic databases were searched for studies on HT and UA from inception to October 31, 2023. Two researchers independently reviewed the studies for inclusion. STATA Software 16.0 was used to compute the standardized mean difference (SMD) and 95% confidence interval (CI) for the pooled and post-outlier outcomes. Heterogeneity was evaluated using the I<jats:sup>2<\/jats:sup> statistic and the Galbraith plot. Additionally, sensitivity analysis was performed. Lastly, Begg\u2019s funnel plot and Egger\u2019s test were used to assess publication bias.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 11 studies involving 4,608 patients were included in the meta-analysis. The pooled SMD forest plot (SMD\u2009=\u2009\u22120.313, 95% CI\u2009=\u2009\u22120.586\u2013\u22120.039, <jats:italic>p<\/jats:italic> =\u20090.025) displayed that low UA concentrations were linked to a higher risk of HT in post-AIS patients. However, heterogeneity (I<jats:sup>2<\/jats:sup> =\u200989.8%, <jats:italic>p<\/jats:italic> &amp;lt;\u20090.001) was high among the studies. Six papers fell outside the Galbraith plot regression line, and there exclusive resulted in the absence of heterogeneity (I<jats:sup>2<\/jats:sup> =\u200952.1%, <jats:italic>p<\/jats:italic> =\u20090.080). Meanwhile, repeated SMD analysis (SMD\u2009=\u2009\u22120.517, 95% CI\u2009=\u2009\u22120.748\u2013\u22120.285, <jats:italic>p<\/jats:italic> =\u20090.000) demonstrated that the HT group had lower UA concentrations. Finally, Begg\u2019s funnel plot and Egger\u2019s test indicated the absence of publication bias in our meta-analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This meta-analysis illustrated a substantial connection between UA concentrations and HT, with lower UA concentrations independently linked with a higher risk of HT post-AIS. These results lay a theoretical reference for future studies.<\/jats:p><jats:p><jats:bold>Systematic review registration:<\/jats:bold><jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/CRD42023485539<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1378912","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T04:54:07Z","timestamp":1721883247000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between uric acid and the risk of hemorrhagic transformation in patients with acute ischemic stroke: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Ying","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxi","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12933-023-01925-1","article-title":"Insulin resistance estimated by estimated glucose disposal rate predicts outcomes in acute ischemic stroke patients","volume":"22","author":"Lu","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e2319231","DOI":"10.1001\/jamanetworkopen.2023.19231","article-title":"High-definition cathodal direct current stimulation for treatment of acute ischemic stroke: a randomized clinical trial","volume":"6","author":"Bahr-Hosseini","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1182\/blood.2021014958","article-title":"Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKC\u03b2 phosphorylation of occludin","volume":"140","author":"Goncalves","year":"2022","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1161\/hs0402.105927","article-title":"Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke","volume":"33","author":"Chamorro","year":"2002","journal-title":"Stroke"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1038\/s41467-023-40564-8","article-title":"Deep-learning based detection of vessel occlusions on CT-angiography in patients with suspected acute ischemic stroke","volume":"14","author":"Brugnara","year":"2023","journal-title":"Nat Commun"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1161\/strokeaha.123.043937","article-title":"Medical management versus endovascular treatment for large-vessel occlusion anterior circulation stroke with low NIHSS","volume":"54","author":"Safouris","year":"2023","journal-title":"Stroke"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e2325415","DOI":"10.1001\/jamanetworkopen.2023.25415","article-title":"Efficacy and safety of recombinant human Prourokinase in the treatment of acute ischemic stroke within 4.5 hours of stroke onset: a phase 3 randomized clinical trial","volume":"6","author":"Song","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/jamaneurol.2023.1449","article-title":"Symptomatic intracranial hemorrhage with Tenecteplase vs Alteplase in patients with acute ischemic stroke: the comparative effectiveness of routine Tenecteplase vs Alteplase in acute ischemic stroke (CERTAIN) collaboration","volume":"80","author":"Warach","year":"2023","journal-title":"JAMA Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1001\/jama.2023.7827","article-title":"Dual antiplatelet therapy vs Alteplase for patients with minor nondisabling acute ischemic stroke: the ARAMIS randomized clinical trial","volume":"329","author":"Chen","year":"2023","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e502","DOI":"10.1212\/wnl.0000000000207460","article-title":"Blood-brain barrier permeability and kinetics of inflammatory markers in acute stroke patients treated with Thrombectomy","volume":"101","author":"Bani-Sadr","year":"2023","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/ana.26478","article-title":"Parenchymal hemorrhage rate is associated with time to reperfusion and outcome","volume":"92","author":"Olivot","year":"2022","journal-title":"Ann Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/s0140-6736(98)08020-9","article-title":"Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian acute stroke study Investigators","volume":"352","author":"Hacke","year":"1998","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1161\/strokeaha.121.037411","article-title":"Association of Stroke Subtype with Hemorrhagic Transformation Mediated by Thrombectomy pass: data from the ANGEL-ACT registry","volume":"53","author":"Tong","year":"2022","journal-title":"Stroke"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"107216","DOI":"10.1016\/j.intimp.2020.107216","article-title":"Neuroinflammation in hemorrhagic transformation after tissue plasminogen activator thrombolysis: potential mechanisms, targets, therapeutic drugs and biomarkers","volume":"90","author":"Ma","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.5551\/jat.RV16006","article-title":"Therapeutic strategies to attenuate hemorrhagic transformation after tissue plasminogen activator treatment for acute ischemic stroke","volume":"24","author":"Kanazawa","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1161\/strokeaha.121.034408","article-title":"Blood pressure trajectory groups and outcome after endovascular Thrombectomy: a multicenter study","volume":"53","author":"Petersen","year":"2022","journal-title":"Stroke"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"594613","DOI":"10.3389\/fneur.2020.594613","article-title":"Blood-brain barrier disruption and hemorrhagic transformation in acute ischemic stroke: systematic review and meta-analysis","volume":"11","author":"Arba","year":"2020","journal-title":"Front Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.actbio.2022.10.022","article-title":"Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood-brain barrier disruption in murine ischemic stroke models","volume":"154","author":"Qiu","year":"2022","journal-title":"Acta Biomater"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s12035-015-9134-1","article-title":"Serum uric acid levels and outcomes after acute ischemic stroke","volume":"53","author":"Wang","year":"2016","journal-title":"Mol Neurobiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1111\/ene.15521","article-title":"Association between serum uric acid to serum creatinine ratio and poor functional outcomes in patients with acute ischemic stroke","volume":"29","author":"Gong","year":"2022","journal-title":"Eur J Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1212\/wnl.0000000000207825","article-title":"Uric acid: a translational journey in Cerebroprotection that spanned preclinical and human data","volume":"101","author":"Leira","year":"2023","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/art.24164","article-title":"Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study","volume":"61","author":"Chen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1161\/strokeaha.123.042708","article-title":"Cumulative serum uric acid exposure and its time course with the risk of incident stroke","volume":"54","author":"Tian","year":"2023","journal-title":"Stroke"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1161\/01.Str.0000081983.34771.D2","article-title":"Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke","volume":"34","author":"Weir","year":"2003","journal-title":"Stroke"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1253\/circj.71.1120","article-title":"Serum uric acid as an independent predictor of early death after acute stroke","volume":"71","author":"Karagiannis","year":"2007","journal-title":"Circ J"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1161\/strokeaha.116.014672","article-title":"Uric acid therapy prevents early ischemic stroke progression: a tertiary analysis of the URICO-ICTUS trial (efficacy study of combined treatment with uric acid and r-tPA in acute ischemic stroke)","volume":"47","author":"Amaro","year":"2016","journal-title":"Stroke"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/jci42344","article-title":"Uric acid transport and disease","volume":"120","author":"So","year":"2010","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s12035-020-02115-w","article-title":"Uric acid neuroprotection associated to IL-6\/STAT3 signaling pathway activation in rat ischemic stroke","volume":"58","author":"Aliena-Valero","year":"2021","journal-title":"Mol Neurobiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/nrl.0000000000000234","article-title":"Serum uric acid level and outcome of patients with ischemic stroke: a systematic review and meta-analysis","volume":"24","author":"Lei","year":"2019","journal-title":"Neurologist"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"609528","DOI":"10.3389\/fmed.2020.609528","article-title":"The comorbid relationship between migraine and asthma: a systematic review and meta-analysis of population-based studies","volume":"7","author":"Wang","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1016\/j.dsx.2019.11.007","article-title":"Serum cystatin C as an early marker of nephropathy among type 2 diabetics: a meta-analysis","volume":"13","author":"Arceo","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1007\/s10072-021-05760-8","article-title":"Lower uric acid level may be associated with hemorrhagic transformation after intravenous thrombolysis","volume":"43","author":"Tian","year":"2022","journal-title":"Neurol Sci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.21037\/atm-22-4494","article-title":"Increased serum uric acid level is associated with better outcome after endovascular treatment for acute ischemic stroke-a prospective cohort study","volume":"10","author":"Bai","year":"2022","journal-title":"Ann Transl Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/ene.14202","article-title":"Uric acid level and risk of symptomatic intracranial haemorrhage in ischaemic stroke treated with endovascular treatment","volume":"27","author":"Yuan","year":"2020","journal-title":"Eur J Neurol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"106032","DOI":"10.1016\/j.clineuro.2020.106032","article-title":"Comparison of the risk factors of hemorrhagic transformation between large artery atherosclerosis stroke and cardioembolism after intravenous thrombolysis","volume":"196","author":"Yang","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12031-019-01404-x","article-title":"Serum uric acid and risk of hemorrhagic transformation in patients with acute ischemic stroke","volume":"70","author":"Song","year":"2020","journal-title":"J Mol Neurosci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s11011-020-00601-7","article-title":"Lower uric acid level may be associated with hemorrhagic transformation but not functional outcomes in patients with anterior circulation acute ischemic stroke undergoing endovascular thrombectomy","volume":"35","author":"Chen","year":"2020","journal-title":"Metab Brain Dis"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"262","DOI":"10.19854\/j.cnki.1008-2425.2021.05.0002","article-title":"Distribution characteristics of risk factors for acute ischemic stroke and influencing factors of hemorrhagic transformation after stent thrombectomy. Chinese journal of","volume":"34","author":"Chen","year":"2021","journal-title":"Stereotact Funct Neurosurg"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3969\/j.issn.1009-0126.2021.06.016","article-title":"Value of serum calcium and UA levels before thrombolysis for predicting HT in AIS patients after intravenous thrombolysis","volume":"23","author":"Sun","year":"2021","journal-title":"Chin J Geriatr Heart Brain Vessel Dis"},{"key":"ref44","first-page":"85","article-title":"Clinical observation of intrusive bleeding during intravenous rt-PA thrombolysis in patients with acute ischemic stroke","volume":"24","author":"Zhang","year":"2021","journal-title":"Chin Gen Pract"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3760\/cma.j.cn121430-20200713-00517","article-title":"Analysis of influencing factors of neurological function recovery and cerebral hemorrhage transformation after intravenous thrombolysis in patients with acute ischemic stroke","volume":"32","author":"Chen","year":"2020","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.15887\/j.cnki.13-1389\/r.2017.36.008","article-title":"Analysis of risk factors related to hemorrhagic transformation after thrombolytic therapy in patients with acute ischemic stroke","volume":"10","author":"Wei","year":"2017","journal-title":"Chin J Clin Ration Drug Use"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.atherosclerosis.2020.01.025","article-title":"Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention","volume":"297","author":"Lim","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"135098","DOI":"10.1016\/j.neulet.2020.135098","article-title":"The association between serum uric acid level and the risk of cognitive impairment after ischemic stroke","volume":"734","author":"Sun","year":"2020","journal-title":"Neurosci Lett"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s10072-019-03737-2","article-title":"Association of uric acid with stenosis of intracranial and extracranial arteries in elderly patients with cerebral infarction","volume":"40","author":"Li","year":"2019","journal-title":"Neurol Sci"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/0891-5849(93)90143-i","article-title":"Towards the physiological function of uric acid","volume":"14","author":"Becker","year":"1993","journal-title":"Free Radic Biol Med"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"102237","DOI":"10.1016\/j.plefa.2020.102237","article-title":"Effects of uric acid on oxidative and nitrosative stress and other related parameters in SH-SY5Y human neuroblastoma cells","volume":"165","author":"M\u00e1rmol","year":"2021","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1177\/0271678x20967459","article-title":"Effect of uric acid in animal models of ischemic stroke: a systematic review and meta-analysis","volume":"41","author":"Aliena-Valero","year":"2021","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e0219402","DOI":"10.1371\/journal.pone.0219402","article-title":"Relationship between infarct size and serum uric acid levels during the acute phase of stroke","volume":"14","author":"Fern\u00e1ndez-Gajardo","year":"2019","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11910-015-0604-7","article-title":"Administration of Uric Acid in the emergency treatment of acute ischemic stroke","volume":"16","author":"Llull","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/ana.24378","article-title":"Uric acid improves glucose-driven oxidative stress in human ischemic stroke","volume":"77","author":"Amaro","year":"2015","journal-title":"Ann Neurol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/s1474-4422(14)70054-7","article-title":"Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 213\/3 trial","volume":"13","author":"Chamorro","year":"2014","journal-title":"Lancet Neurol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2174\/1567202619666220707093427","article-title":"U-shaped association between serum uric acid and hemorrhagic transformation after intravenous thrombolysis","volume":"19","author":"Cheng","year":"2022","journal-title":"Curr Neurovasc Res"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fneur.2023.1103270","article-title":"Sex-dependent association analysis between serum uric acid and spontaneous hemorrhagic transformation in patients with ischemic stroke","volume":"14","author":"Tang","year":"2023","journal-title":"Front Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1378912\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T04:54:22Z","timestamp":1721883262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1378912\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":58,"alternative-id":["10.3389\/fneur.2024.1378912"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1378912","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]},"article-number":"1378912"}}